Drug intelligence / Profile preview

ginsenoside Rh1

Development stage
Unknown
Modality
Small Molecules
Administration
Oral (most Research Formulations), Intraperitoneal (in Animal Studies)
01

Overview

Ginsenoside Rh1 is a natural triterpenoid saponin and one of the major active constituents extracted from red ginseng (Panax ginseng). It belongs to the dammarane-type tetracyclic triterpenoids and is structurally characterized as a beta-D-glucoside of protopanaxadiol. Mechanistically, Rh1 demonstrates anti-inflammatory, antioxidant, immunomodulatory, estrogenic, neuroprotective, and cytoprotective properties primarily in vitro and in animal models. It acts through multiple targets, including modulation of inflammatory signaling, antioxidant pathways, and mitochondrial autophagy mechanisms. Rh1 has also shown positive effects on nervous system function and may support cognitive enhancement and neuroprotection through increased cell survival and upregulation of brain-derived neurotrophic factor (BDNF) in animal models. Its cytotoxicity is variable and cell-type dependent. There is currently no approved human pharmaceutical indication for ginsenoside Rh1; clinical evidence is lacking, and further investigation, particularly human trials, is recommended[1][4][7][13][15].

Other names
ginsenoside Rh1(20S)-ginsenoside Rh1Sanchinoside B2Prosapogenin A2(S)-ginsenoside Rh1Sanchinoside rh1
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)FOS (Activator Protein 1)

Beyond the preview

Go deeper on ginsenoside Rh1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ginsenoside Rh1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call